NEW YORK (GenomeWeb) – SeraCare Life Sciences announced yesterday that it has signed an agreement under which its Seraseq aneuploidy reference materials will be incorporated into a non-invasive prenatal testing (NIPT) external quality assessment (EQA) program being developed by the United Kingdom National External Quality Assessment Service (UK NEQAS).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.